Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project

John E. Ware, Barbara Gandek · Journal of Clinical Epidemiology · 1998 · 2.6K citations

Quality Of Life, Life Assessment, Health Outcome +5

Normative data for the HADS from a large non‐clinical sample

Joanne Crawford, Julie D. Henry, Caroline Crombie et al. · British Journal of Clinical Psychology · 2001 · 815 citations · Full text

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).

Douglas A. Drossman, Brenda B. Toner, William E. Whitehead et al. · Gastroenterology · 2003 · 612 citations

Trial Registry, Pain Disorders, Functional Gastrointestinal Disorder +12

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT₃ receptor antagonist

Camilleri, Mayer, Drossman et al. · Alimentary Pharmacology & Therapeutics · 1999 · 372 citations · Full text

Impact of irritable bowel syndrome on quality of life

William E. Whitehead, Charles K. Burnett, Edwin W. Cook et al. · Digestive Diseases and Sciences · 1996 · 295 citations

Quality Of Life, Life Satisfaction, Functional Gastrointestinal Disorder +5